Pitfalls in genetic testing: The story of missed SCN1A mutations

EuroEPINOMICS-RES Dravet working group

Research output: Contribution to journalArticlepeer-review

47 Scopus citations


Background Sanger sequencing, still the standard technique for genetic testing in most diagnostic laboratories and until recently widely used in research, is gradually being complemented by next-generation sequencing (NGS). No single mutation detection technique is however perfect in identifying all mutations. Therefore, we wondered to what extent inconsistencies between Sanger sequencing and NGS affect the molecular diagnosis of patients. Since mutations in SCN1A, the major gene implicated in epilepsy, are found in the majority of Dravet syndrome (DS) patients, we focused on missed SCN1A mutations. Methods We sent out a survey to 16 genetic centers performing SCN1A testing. Results We collected data on 28 mutations initially missed using Sanger sequencing. All patients were falsely reported as SCN1A mutation-negative, both due to technical limitations and human errors. Conclusion We illustrate the pitfalls of Sanger sequencing and most importantly provide evidence that SCN1A mutations are an even more frequent cause of DS than already anticipated.

Original languageEnglish (US)
Pages (from-to)457-464
Number of pages8
JournalMolecular Genetics and Genomic Medicine
Issue number4
StatePublished - Jul 1 2016


  • Dravet syndrome
  • Epilepsy
  • Genetic screening
  • Next-generation sequencing
  • Sanger sequencing

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Pitfalls in genetic testing: The story of missed SCN1A mutations'. Together they form a unique fingerprint.

Cite this